Nils is a serial entrepreneur with a passion for biomedicine. As co-founder of TruVenturo, he has helped over 30 early-stage startups raise funding, with three achieving valuations over $100M.
Dr. Ole Mensching
Ole is a serial entrepreneur, HR expert and former board member of hyper-growth companies with more than 10 years of investment and operational experience who previously co-founded and sold CareerTeam.
Dr. Marianne Mertens
Marianne has more than ten years of experience in the life science industry spanning venture investing, strategy consulting and research and was previously with Wellinton Partners as well as High-Tech Gründerfonds.
Jan Adams, Ph.D., MBA
Jan is a Kauffman Fellow, who previously headed commercial activities at the Merck KGaA Innovation Center and was Managing Director of early stage VC EMBL Ventures.
Dr. Alexandra Bause
Co-Founder & Venture Partner
Alexandra is dedicated to longevity research since her studies at Harvard and is responsible for identifying company building opportunities with global leading research institutes and researchers.
Dr. Anela Vukoja
Anela specializes on R&D strategy and on developing and implementing data-driven processes after previously consulting Top Tier VCs and hedge funds at boutique consultancy Cantenion.
Frederick Beddingfield MD, Ph.D.
Laurent Audoly, Ph.D.
Chris Shepard, Ph.D.
Chris has supported over $1.5bn in investments and transactions in biotechnology/pharma spanning research, development, clinical trial design, and personalized medicine and biomarkers.
Dr. Gerd Hummel
Executive Vice President R&D
Gerd has more than 20 years of experience in pharma R&D and previously led research and R&D, among others in the field at Jerini and Oryzon Genomics (leading drug development in epigenetic-based therapeutics).
Dr. Stefan Hoenow
Principal Scientist & Venture Developer
Stefan uses his scientific background to develop projects and design experiments to understand various aspects of aging, specializing in the aging immune system and identifying models to test molecular interventions.
Pascale Eede, Ph.D.
Pascale works on internal venture creation and external investments using her background in early-stage drug discovery. Her works has been published in high-ranking scientific journals.